Objectives: To investigate the association between body mass index (BMI) and sexual functioning in gynaecologic cancer patients. To determine the association between socio-economic deprivation and sexual functioning.
for women and negatively influence their quality of life. 2, 3 In addition, gynaecological cancer and its treatment directly influence a woman's reproductive organ and sexual functioning. 4 Sexual functioning is an important yet underreported part of a woman's quality of life. Previous studies have shown that women often experience serious disruptions in sexual function after treatment for gynaecological cancer. [5] [6] [7] This can cause women to feel less interested in sexual relations, with negative impact on their relationship with partners. 8 Therefore, the detection and treatment of sexual problems in women with gynaecological cancer are important, but are still met with reluctance by clinicians. 8 Together with the rise in prevalence of obesity in the general population 9 and the increased risk of cancer associated with obesity, a significant proportion of women with gynaecological cancer are obese. 10 In 2016, 40% of adult women worldwide were overweight (body mass index [BMI], 25-29.9) , with a further 15% being obese (BMI ≥ 30).
11
There is a strong relationship between obesity and low socio-economic status (SES) in developed countries. 12, 13 In addition, socio-economic deprivation has been shown to be associated with an increase in both the incidence and survival of gynaecological cancers. 14 A lower socioeconomic status has also been independently associated with poorer quality of life in gynaecologic cancer patients after treatment. 15 An emerging body of evidence indicates that obesity negatively impacts the quality of life throughout the cancer care pathway. 16 However, the association between BMI and sexual functioning in gynaecological cancer patients remains unclear.
The aim of this study is to determine the association between BMI and sexual functioning in women undergoing treatment for gynaecological cancer. In addition, we plan to assess the association between socio-economic deprivation and sexual functioning. 
| METHODS

| Statistical methods
With a background incidence of 40% of sexual dysfunction in the general female population 22 and 63% in gynaecological cancer patients, 23 we performed a sample size calculation (α = 0.05 and power of 80%).
The sample size was calculated to be 146 patients.
Continuous outcomes were presented as medians and interquartile ranges, and categorical data were presented as frequencies and proportions. To avoid discarding data due to missing entries, we adopted a simple imputation scheme for BMI and IMD. For IMD, the missing observations were replaced with the median over the whole data set.
For BMI, if one entry was missing, it was replaced with the median of the other two entries. However, if two entries were missing, they were replaced with the one observed entry. If all three BMI entries were missing, BMI was calculated as the median over the complete data set.
For the FSFI scores, no imputation strategy has been applied, but a principled approach was used, which allows inference without discarding data and without imputation. The FSFI scores are represented as intervals 24 ; a completely unobserved score will be represented as the interval 2-36. There was no difference between the 3-and 12-month postoperative data for FSFI; therefore, to reduce the complexity of the model, we used a binary factor "pre-op/post-op." The patients with final histology "benign" only answered the preoperative questionnaire; therefore, they were excluded from further analysis at 3 and 12 months postoperative.
The association between BMI and the FSFI outcomes was assessed using semiparametric regression analysis, while correcting for confounders such as age and treatment modality. A multistage bootstrap procedure was implemented to take into account potential intrasubject correlations. Data were analysed by using R3.4.3 and the icenReg library. 24 
| RESULTS
A total number of 257 patients were approached, of which 170 patients consented, resulting in a recruitment rate of 66%. Four patients dropped out of the study that resulted in a total study population of 166 women with FSFI data of 498 observations; see Figure 1 .
| Baseline characteristics
The demographics and baseline characteristics of the study cohort are presented in 
| FSFI and BMI
In endometrial, ovarian, and vulvar cancer patients, low values of BMI were associated with low FSFI scores, whereas high values of BMI were associated with higher scores (Table 2 ). However, in cervical cancer patients, high BMI was inversely associated with FSFI.
| FSFI, age, and cancer type
There was a relationship between FSFI scores and age at diagnosis, with older women experiencing lower scores and younger women experiencing higher scores. However, for older women, there are not many observed scores (Table 2) . Cervical cancer patients were younger (median age, 33), with a lower BMI and higher IMD than patients affected by other cancer types. They also have higher average FSFI scores (median score, 20; Table 2 ). Vulvar cancer patients on the other hand had consistently low FSFI scores and were older of age (median age, 75).
The cumulative distribution of FSFI scores using the Turnbull nonparametric estimates, 24 stratified by cancer type, showed that vulval and cervix cancer are associated with extreme scores. The distribution of FSFI scores for the group of women with final histology benign (measured preoperatively only) is similar to the FSFI scores for women with endometrial and ovarian cancer (see Figure S1 ).
| FSFI over time
The median FSFI score preoperatively and postoperatively with bootstrapped 95% confidence intervals (CI) suggests a difference in the score preoperatively and 3 and 12 months postoperatively, but no appreciable difference between the latter two. Cervical cancer FIGURE 1 Flow chart of recruitment patients have the largest increase in the median FSFI score after surgery (from 10.3 to 19.7), followed by endometrial cancer patients (from 5.8 to 12); although in all cases, the confidence intervals are quite large due to the small number of exact FSFI scores (see Table S1 ).
| FSFI and socio-economic deprivation
There was no clear evidence of a relationship between IMD and FSFI (data not shown).
| Patient comments on FSFI
Interestingly, patients provided us with written comments on the FSFI form; these are presented in Data S1.
| Semiparametric regression analysis
The hazard ratios (HRs) for every variable are presented in Table 3 with the value larger than one corresponding to a reduction of the and vaginal dryness. 26 Our study showed that nearly all women included had low FSFI scores (sexual dysfunction), which is in keeping with previous studies. 27 When assessing the relationship between female sexual functioning and BMI following gynaecologic oncology procedures, our data suggest an association between BMI and FSFI scores, where a higher BMI is associated with better sexual functioning. This is especially seen in women with vulvar cancer, but there seems to be a similar trend for endometrial and ovarian cancer. However, for cervical cancer, high BMI was not associated with improved FSFI score, and indeed, a trend towards an inverse association was noted; nevertheless, this did not reach the significant level. An explanation may be that higher levels of BMI are associated with higher oestrogen levels, due to oestrogen production in adipose tissue. 28 This has a positive effect on vaginal moistening, which could explain why overweight women with vulvar cancer reported less sexual problems. 29 The fact that high BMI was associated with better sexual functioning in women with vulvar, endometrial, and ovarian cancer and not in women with cervical cancer might be explained by the fact most women with cervical cancer were premenopausal, whereas the women in the other groups tended to be postmenopausal. Our results are in line with a study done by Oldenburg et al, which showed that higher BMI was inversely associated with sexual/vaginal problems in endometrial cancer. 29 However, Armbruster et al found no association between BMI and sexual function or sexual interest in endometrial cancer survivors at least 6 months after treatment. 30 A recent study by this team reported an association between physical inactivity and poorer sexual functioning in ovarian cancer survivors; however, no association between BMI and sexual dysfunction was found. 31 For vulvar and cervical cancer, the literature is scarce, and the link between BMI and sexual functioning is unclear. Therefore, further research is needed to further investigate other factors that can influence sexual functioning including the impact of cancer diagnosis on relations and psychological morbidity.
Age is a known risk factor for sexual dysfunction in the general population 32 ; furthermore, Gao et al showed age as a risk factor of sexual dysfunction in endometrial cancer survivors. 5 Our data suggest a relationship between sexual functioning and age at diagnosis, with older women experiencing lower scores and younger women experiencing higher scores. Older women were also less likely to complete the FSFI, and elderly women did show lower scores; however, they frequently reported not being sexually active but satisfied with their lack of sexual activity.
Remarkably, our study showed lower sexual functioning scores preoperatively compared with postoperatively (both at 3 months and 1 year); this may be due to pretreatment anxiety, depression, and anger that can influence relationships and sexuality. 33 The preoperative period represents a time of increased stress and anxiety while waiting for new or potential cancer diagnosis. 34 This can also explain why patients with a final benign diagnosis had low FSFI scores preoperatively in this study. After treatment, the observed FSFI may be secondary to the certainty of diagnosis and treatment success.
Previous studies have shown improvement in sexual dysfunction over shorter follow-up period (up to 6 months); however, no studies have demonstrated changes over 1 year follow-up; therefore, further research is needed. 35 The socio-economic status (SES) and deprivation (IMD) are important predictors of health and affect the survival from gynaecological cancers. 14 Since previous research showed a poorer quality of life in more deprived patients with gynaecologic cancer, we examined the association between sexual functioning and deprivation. However, we did not find an association between female sexual dysfunction and overall deprivation as measured by the Index of Multiple Deprivation.
This study offers new information on the relationship of BMI and sexual functioning in women who are treated for gynaecologic cancer.
Our study suggests that age and BMI are associated with sexual functioning in gynaecological cancer patients, with overweight and obese patients reporting better sexual functioning in endometrial, ovarian, and vulvar cancer patients. This is one of the first studies to evaluate different aspects of sexuality and sexual functioning including arousal, satisfaction, orgasm, and pain preoperatively and with 1 year followup in association with BMI indices. The strengths of our study include the prospective cohort design with patient-reported data collected preoperative with subsequent follow-up for 1 year at two different intervals. A standardized, validated questionnaire was used, which is validated not only in the general population but for cancer patients as well. 19 
| CONCLUSION
High BMI is associated with improved sexual functioning in vulvar, ovarian, and endometrial cancer patients, but not in cervical cancer patients. However, there is no correlation between socio-economic deprivation and sexual functioning. Further research is needed to assess these associations in more detail.
Increasing awareness of the impact of a gynaecological cancer diagnosis on sexual functioning can improve care and counselling in the perioperative setting.
| Clinical implications
BMI has an impact on the psychosexual functioning of women with gynaecological cancer with higher BMI being associated with better sexual functioning. This is not the case for cervical cancer; therefore, clinicians will need to take measures in addressing any psychosexual issues during and after treatment. This is important in order to improve their quality of life.
| Study limitations
Limitations of this study are the relatively small study population and the limited number of fully observed scores making the analysis of the FSFI data a complex problem. In addition, this study possibly involved a somewhat select group of women-those who were willing to complete the questionnaire. Because we only have a small sample size of vulvar and cervical cancer patients, we were limited in our analysis. Sexuality remains a difficult but important topic that is reflected in the fact some patients who agreed to participate in the study did not fill out the sexual functioning questionnaires.
